Front Row Advisors LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
Front Row Advisors LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$3
-99.9%
730.0%0.00%0.0%
Q3 2022$4,0000.0%730.0%0.00%0.0%
Q2 2022$4,000
-33.3%
730.0%0.00%0.0%
Q1 2022$6,000
+50.0%
730.0%0.00%
+100.0%
Q4 2021$4,0000.0%730.0%0.00%
-50.0%
Q3 2021$4,0000.0%730.0%0.00%0.0%
Q2 2021$4,000
-20.0%
730.0%0.00%0.0%
Q1 2021$5,000
+25.0%
730.0%0.00%0.0%
Q4 2020$4,000
-20.0%
730.0%0.00%
-33.3%
Q3 2020$5,000
+25.0%
730.0%0.00%
+50.0%
Q2 2020$4,000
+33.3%
730.0%0.00%0.0%
Q1 2020$3,0000.0%730.0%0.00%0.0%
Q4 2019$3,0000.0%730.0%0.00%0.0%
Q3 2019$3,0000.0%730.0%0.00%0.0%
Q2 2019$3,0000.0%730.0%0.00%0.0%
Q1 2019$3,0000.0%730.0%0.00%
-33.3%
Q4 2018$3,0000.0%730.0%0.00%
+50.0%
Q3 2018$3,0000.0%730.0%0.00%0.0%
Q2 2018$3,000
+50.0%
730.0%0.00%
+100.0%
Q1 2018$2,000
-33.3%
730.0%0.00%
-50.0%
Q4 2017$3,000730.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Tamarack Advisers, LP 360,000$21,845,0006.19%
Gagnon Advisors, LLC 213,217$12,938,0004.92%
GAGNON SECURITIES LLC 499,333$30,300,0004.30%
Spyglass Capital Management LLC 2,117,673$128,500,0002.86%
NEUMEIER POMA INVESTMENT COUNSEL LLC 646,530$39,231,0002.30%
Paulson & Co. 1,273,161$77,255,0001.85%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 212,112$12,871,0001.44%
Tygh Capital Management, Inc. 152,332$9,244,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,147,000$69,600,0001.24%
Rock Springs Capital Management LP 1,025,000$62,197,0001.23%
View complete list of PACIRA PHARMACEUTICALS INC shareholders